divendres, 8 d’agost del 2014

Press Release: Medtronic receives FDA approval for attain Performa Quadripolar lead and Viva Quad CRT-Ds in United States




New system helps physicians deliver cardiac resynchronization therapy optimally and efficiently to heart failure patients.





Press Release: Medtronic receives FDA approval for attain Performa Quadripolar lead and viva Quad CRT-Ds in United States

Medtronic

News Well, Press Release, Regulatory/Clearance, Cardiac Rhythm Management, Food & Drug Administration (FDA), Minnesota, Pre-Market Approval (PMA)

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sqSUBb
a

Cap comentari:

Publica un comentari a l'entrada